Sabrina Kamran, Phd, Ca-Am Email & Phone Number

Boston, MA, US

Boston, MA, US

London, GB

Evaluated in-licensed technologies from 23 partnerships by liaising with inventing scientists and technology transfer offices to gather product information in order to effectively market these technologies to Ximbio's customersExpanded partnerships in North America by 39%, generating 11 new partnership including new markets in Texas, Florida and Puerto.

Lead a 3-stage screening process that selects from among 15 early stage life science and medical device companies, subsequently presented to over 20 angel investors every quarter

Kirkland, Washington, US

Prevencio is a Life Science diagnostics company developing cardiac biomarker panels for the diagnosis of various cardiovascular diseases (CAD, CVE, PAD, AS).Identified over 20 academic researchers in cardiovascular clinical trials and coordinated with Prevencio VP of Clinical Development, resulting in 3 academic partnerships for external validation of.

Olico Therapeutics is a team at UW developing novel agonistic antibodies by leveraging novel protein design technology to create therapies for cancer and previously untreatable diseases.Created customer discovery plan and strategic market analysis to identify 8 initial drug targets for therapeutic development and identifying corresponding key industry.

ecosVC® enables science and engineering innovators to translate their research into commercial innovations to meet market needs. Organized workshop logistics for Lens of the Market® training series and marketing for the Innovation Track at the 2017 American Chemical Society Northwest Regional MeetingData management for Lens of the Market® survey feedback

Seattle, WA, US

https://gardnerlab.org/Thesis Title: Ubiquitin-Mediated Regulation of RNA Polymerase I in Saccharomyces cerevisiaeManaged and performed experiments pertaining to projects involved in understanding both yeast and mammalian ubiquitin regulation of RNA polymerase I pertaining to uncovering novel therapeutic targetsMentored undergraduates in their research.

Z-ion+ Technologies is developing a quasi-zwitterionic, non-stick coating that can be applied to any vascular medical device to decrease the risk of blood clot formation. Developed strategic market analysis for initial target markets being contemplated for commercializationCreated business plan and established scientific and business development milestones.

A Plus Pediatrics offers medical care to newborns and to 18 years of age.Gained an understanding of small scale medical practice decision making, insurance reimbursement procedures and how care gaps are closedWorked with patients and parents to gain accurate medical histories during sick and well examsAdministered vaccinations and maintain vaccine records.

The Spine and Pain Institute of New York is dedicated to the diagnosis, treatment and management of acute and chronic pain. We strive to provide our patients with an accurate diagnosis to relieve pain utilizing the least invasive treatment methods. Gained an understanding of healthcare decision making in multi-practice settingPrepared patients for.

Allentown, PA, US

CRLA Level III

Doctor Of Philosophy (Phd), Pharmacology

Bachelor Of Science (B.S.), Biology

Education record